449 related articles for article (PubMed ID: 4005772)
41. The case for B.C.G.
Tripathy SP
Ann Natl Acad Med Sci; 1983; 19(1):11-21. PubMed ID: 12341889
[TBL] [Abstract][Full Text] [Related]
42. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
[TBL] [Abstract][Full Text] [Related]
43. The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok.
Padungchan S; Konjanart S; Kasiratta S; Daramas S; ten Dam HG
Bull World Health Organ; 1986; 64(2):247-58. PubMed ID: 3488839
[TBL] [Abstract][Full Text] [Related]
44. Tuberculosis prevention: where do we go from here?
Warndorff DK
Afr Health; 1996 Nov; 19(1):21-2. PubMed ID: 12291917
[TBL] [Abstract][Full Text] [Related]
45. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
[TBL] [Abstract][Full Text] [Related]
46. The effect of neonatal bacille Calmette-Guérin vaccination on purified protein derivative skin test results in Canadian aboriginal children.
Reid JK; Ward H; Marciniuk D; Hudson S; Smith P; Hoeppner V
Chest; 2007 Jun; 131(6):1806-10. PubMed ID: 17400666
[TBL] [Abstract][Full Text] [Related]
47. PUVALLUTTUQ: AN EPIDEMIC OF TUBERCULOSIS AT ESKIMO POINT, NORTHWEST TERRITORIES.
MOORE PE
Can Med Assoc J; 1964 May; 90(21):1193-202. PubMed ID: 14144539
[TBL] [Abstract][Full Text] [Related]
48. Tuberculin reactivity and tuberculosis epidemiology in the Pakaanóva (Wari') Indians of Rondônia, south-western Brazilian Amazon.
Escobar AL; Coimbra CE; Camacho LA; Santos RV
Int J Tuberc Lung Dis; 2004 Jan; 8(1):45-51. PubMed ID: 14974745
[TBL] [Abstract][Full Text] [Related]
49. Does BCG vaccination protect the newborn and young infants?
ten Dam HG; Hitze KL
Bull World Health Organ; 1980; 58(1):37-41. PubMed ID: 6991146
[TBL] [Abstract][Full Text] [Related]
50. Effectiveness of BCG vaccination in England and Wales in 1983.
Sutherland I; Springett VH
Tubercle; 1987 Jun; 68(2):81-92. PubMed ID: 3660468
[TBL] [Abstract][Full Text] [Related]
51. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau.
Roth A; Jensen H; Garly ML; Djana Q; Martins CL; Sodemann M; Rodrigues A; Aaby P
Pediatr Infect Dis J; 2004 Jun; 23(6):544-50. PubMed ID: 15194836
[TBL] [Abstract][Full Text] [Related]
52. [Population projections of registered Indians in Canada, 1991-2015].
Nault F; Gauvin RP; George MV
Cah Que Demogr; 1995; 24(1):109-27. PubMed ID: 12291441
[TBL] [Abstract][Full Text] [Related]
53. Research on BCG vaccination.
ten Dam HG
Adv Tuberc Res; 1984; 21():79-106. PubMed ID: 6433675
[TBL] [Abstract][Full Text] [Related]
54. Selective or universal neonatal BCG immunization: what policy for a district with a high incidence of tuberculosis?
Pharoah PD; Watson JM; Sen S
Public Health; 1996 May; 110(3):179-83. PubMed ID: 8668765
[TBL] [Abstract][Full Text] [Related]
55. The tuberculin skin test is unreliable in school children BCG-vaccinated in infancy and at low risk of tuberculosis infection.
Jacobs S; Warman A; Richardson R; Yacoub W; Lau A; Whittaker D; Cockburn S; Verma G; Boffa J; Tyrrell G; Kunimoto D; Manfreda J; Langlois-Klassen D; Long R
Pediatr Infect Dis J; 2011 Sep; 30(9):754-8. PubMed ID: 21487326
[TBL] [Abstract][Full Text] [Related]
56. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
[TBL] [Abstract][Full Text] [Related]
57. Characteristics of Indigenous primary health care models of service delivery: a scoping review protocol.
Harfield S; Davy C; Kite E; McArthur A; Munn Z; Brown N; Brown A
JBI Database System Rev Implement Rep; 2015 Nov; 13(11):43-51. PubMed ID: 26657463
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of tuberculin reactivity among healthcare workers from a Mexican hospital.
Molina-Gamboa J; Fivera-Morales I; Ponce-de-León-Rosales S
Infect Control Hosp Epidemiol; 1994 May; 15(5):319-20. PubMed ID: 8077644
[TBL] [Abstract][Full Text] [Related]
59. Neonatal BCG vaccination and tuberculin skin sensitivity among schoolchildren of the United Arab Emirates.
Uduman SA; Bener A; Bin Othman SA
Ann Trop Paediatr; 1996 Dec; 16(4):353-7. PubMed ID: 8985534
[TBL] [Abstract][Full Text] [Related]
60. A BCG trial in Canada's native populations.
Young TK
Can Med Assoc J; 1982 Dec; 127(12):1164, 1167. PubMed ID: 7139465
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
